Findcure
Daxing
About Findcure
Findcure focuses on medication development targeting signaling pathways and immunotherapy, including small molecule targeted pharmaceuticals, macromolecular proteins, and antibody therapeutics with independent intellectual property rights.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $14.5M
- Funding stage: Early Stage Venture
- Last round: Series B (Feb 2026)
- Website: findcure-bio.com
- Phone: 010-56315099
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/findcure-2851716 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.